Suppr超能文献

神经性厌食症中物质使用障碍和物质使用的患病率:一项系统评价和荟萃分析。

The prevalence of substance use disorders and substance use in anorexia nervosa: a systematic review and meta-analysis.

作者信息

Devoe Daniel J, Dimitropoulos Gina, Anderson Alida, Bahji Anees, Flanagan Jordyn, Soumbasis Andrea, Patten Scott B, Lange Tom, Paslakis Georgios

机构信息

Department of Psychiatry, Cumming School of Medicine, Mathison Centre for Mental Health Research and Education, University of Calgary, 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, Canada.

Faculty of Social Work, University of Calgary, Calgary, Canada.

出版信息

J Eat Disord. 2021 Dec 11;9(1):161. doi: 10.1186/s40337-021-00516-3.

Abstract

AIM

Individuals with anorexia nervosa (AN) often present with substance use and substance use disorders (SUDs). However, the prevalence of substance use and SUDs in AN has not been studied in-depth, especially the differences in the prevalence of SUDs between AN types [e.g., AN-R (restrictive type) and AN-BP (binge-eating/purge type]. Therefore, this systematic review and meta-analysis aimed to assess the prevalence of SUDs and substance use in AN samples.

METHOD

Systematic database searches of the peer-reviewed literature were conducted in the following online databases: MEDLINE, PsycINFO, Embase, and CINAHL from inception to January 2021. We restricted review eligibility to peer-reviewed research studies reporting the prevalence for either SUDs or substance use in individuals with AN. Random-effects meta-analyses using Freeman-Tukey double arcsine transformations were performed on eligible studies to estimate pooled proportions and 95% confidence intervals (CIs).

RESULTS

Fifty-two studies met the inclusion criteria, including 14,695 individuals identified as having AN (mean age: 22.82 years). Random pooled estimates showed that substance use disorders had a 16% prevalence in those with AN (AN-BP = 18% vs. AN-R = 7%). Drug abuse/dependence disorders had a prevalence of 7% in AN (AN-BP = 9% vs. AN-R = 5%). In studies that looked at specific abuse/dependence disorders, there was a 10% prevalence of alcohol abuse/dependence in AN (AN-BP = 15% vs. AN-R = 3%) and a 6% prevalence of cannabis abuse/dependence (AN-BP = 4% vs. AN-R = 0%). In addition, in terms of substance use, there was a 37% prevalence for caffeine use, 29% prevalence for alcohol use, 25% for tobacco use, and 14% for cannabis use in individuals with AN.

CONCLUSION

This is the most comprehensive meta-analysis on the comorbid prevalence of SUDs and substance use in persons with AN, with an overall pooled prevalence of 16%. Comorbid SUDs, including drugs, alcohol, and cannabis, were all more common in AN-BP compared to AN-R throughout. Therefore, clinicians should be aware of the high prevalence of SUD comorbidity and substance use in individuals with AN. Finally, clinicians should consider screening for SUDs and integrating treatments that target SUDs in individuals with AN. Individuals with anorexia nervosa (AN) may also present with substance use or have a substance use disorder (SUDs). Thus, we conducted a systematic review and meta-analysis to determine the prevalence of substance use and substance use disorders in individuals with AN. We examined published studies that reported the prevalence of either substance use or SUDs in individuals with AN. We found that substance use disorders had a 16% prevalence and that drug abuse/dependence disorders had a prevalence of 7% in those with AN. These rates were much higher in individuals with binge-eating/purging type compared to the restrictive AN. However, many specific substance use disorders and substance use types were low in individuals with AN. Nonetheless, clinicians should be aware of the high prevalence of SUD comorbidity and substance use in individuals with AN.

摘要

目的

神经性厌食症(AN)患者常伴有物质使用及物质使用障碍(SUDs)。然而,AN中物质使用及SUDs的患病率尚未得到深入研究,尤其是不同类型AN(如AN-R,限制型;AN-BP,暴饮暴食/清除型)之间SUDs患病率的差异。因此,本系统评价和荟萃分析旨在评估AN样本中SUDs及物质使用的患病率。

方法

对以下在线数据库进行系统的数据库检索,以查找同行评审文献:MEDLINE、PsycINFO、Embase和CINAHL,检索时间从建库至2021年1月。我们将综述纳入标准限定为报告AN患者中SUDs或物质使用患病率的同行评审研究。对符合条件的研究进行随机效应荟萃分析,采用Freeman-Tukey双反正弦变换来估计合并比例和95%置信区间(CIs)。

结果

52项研究符合纳入标准,包括14695名确诊为AN的个体(平均年龄:22.82岁)。随机合并估计显示,AN患者中物质使用障碍的患病率为16%(AN-BP = 18%,AN-R = 7%)。药物滥用/依赖障碍在AN中的患病率为7%(AN-BP = 9%,AN-R = 5%)。在研究特定滥用/依赖障碍的研究中,AN中酒精滥用/依赖的患病率为10%(AN-BP = 15%,AN-R = 3%),大麻滥用/依赖的患病率为6%(AN-BP = 4%,AN-R = 0%)。此外,在物质使用方面,AN患者中咖啡因使用的患病率为37%,酒精使用的患病率为29%,烟草使用的患病率为25%,大麻使用的患病率为14%。

结论

这是关于AN患者中SUDs和物质使用共病患病率最全面的荟萃分析,总体合并患病率为16%。共病的SUDs,包括药物、酒精和大麻,在AN-BP中始终比AN-R更常见。因此,临床医生应意识到AN患者中SUD共病和物质使用的高患病率。最后,临床医生应考虑对SUDs进行筛查,并将针对SUDs的治疗纳入AN患者的治疗方案中。神经性厌食症(AN)患者也可能伴有物质使用或患有物质使用障碍(SUDs)。因此,我们进行了一项系统评价和荟萃分析,以确定AN患者中物质使用和物质使用障碍的患病率。我们审查了已发表的报告AN患者中物质使用或SUDs患病率的研究。我们发现AN患者中物质使用障碍的患病率为16%,药物滥用/依赖障碍的患病率为7%。与限制型AN相比,暴饮暴食/清除型个体的这些比率要高得多。然而,AN个体中许多特定的物质使用障碍和物质使用类型的患病率较低。尽管如此,临床医生应意识到AN患者中SUD共病和物质使用的高患病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c20/8666057/fc2628240fd0/40337_2021_516_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验